99 related articles for article (PubMed ID: 24647827)
1. Amine-containing molecules and the induction of an expanded lysosomal volume phenotype: a structure-activity relationship study.
Logan R; Kong AC; Axcell E; Krise JP
J Pharm Sci; 2014 May; 103(5):1572-80. PubMed ID: 24647827
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the roles of autophagy and lysosomal trafficking defects in intracellular distribution-based drug-drug interactions involving lysosomes.
Logan R; Kong A; Krise JP
J Pharm Sci; 2013 Nov; 102(11):4173-80. PubMed ID: 23970383
[TBL] [Abstract][Full Text] [Related]
3. Time-dependent effects of hydrophobic amine-containing drugs on lysosome structure and biogenesis in cultured human fibroblasts.
Logan R; Kong AC; Krise JP
J Pharm Sci; 2014 Oct; 103(10):3287-96. PubMed ID: 25042198
[TBL] [Abstract][Full Text] [Related]
4. Quantitation of the lysosomotropic character of cationic amphiphilic drugs using the fluorescent basic amine Red DND-99.
Lemieux B; Percival MD; Falgueyret JP
Anal Biochem; 2004 Apr; 327(2):247-51. PubMed ID: 15051542
[TBL] [Abstract][Full Text] [Related]
5. Cationic amphiphilic drugs cause a marked expansion of apparent lysosomal volume: implications for an intracellular distribution-based drug interaction.
Funk RS; Krise JP
Mol Pharm; 2012 May; 9(5):1384-95. PubMed ID: 22449202
[TBL] [Abstract][Full Text] [Related]
6. A high content screening assay for identifying lysosomotropic compounds.
Nadanaciva S; Lu S; Gebhard DF; Jessen BA; Pennie WD; Will Y
Toxicol In Vitro; 2011 Apr; 25(3):715-23. PubMed ID: 21184822
[TBL] [Abstract][Full Text] [Related]
7. Drug-drug interactions involving lysosomes: mechanisms and potential clinical implications.
Logan R; Funk RS; Axcell E; Krise JP
Expert Opin Drug Metab Toxicol; 2012 Aug; 8(8):943-58. PubMed ID: 22616667
[TBL] [Abstract][Full Text] [Related]
8. Lipophilic cationic drugs increase the permeability of lysosomal membranes in a cell culture system.
Kornhuber J; Henkel AW; Groemer TW; Städtler S; Welzel O; Tripal P; Rotter A; Bleich S; Trapp S
J Cell Physiol; 2010 Jul; 224(1):152-64. PubMed ID: 20301195
[TBL] [Abstract][Full Text] [Related]
9. Lysosomotropic agents. 1. Synthesis and cytotoxic action of lysosomotropic detergents.
Firestone RA; Pisano JM; Bonney RJ
J Med Chem; 1979 Sep; 22(9):1130-3. PubMed ID: 114658
[TBL] [Abstract][Full Text] [Related]
10. Lysosomal adaptation: How cells respond to lysosomotropic compounds.
Lu S; Sung T; Lin N; Abraham RT; Jessen BA
PLoS One; 2017; 12(3):e0173771. PubMed ID: 28301521
[TBL] [Abstract][Full Text] [Related]
11. Identification of lysosomotropic compounds based on the distribution and size of lysosomes.
Seo I; Jha BK; Lim JG; Suh SI; Suh MH; Baek WK
Biochem Biophys Res Commun; 2014 Jul; 450(1):189-94. PubMed ID: 24878535
[TBL] [Abstract][Full Text] [Related]
12. Lysosomal sequestration of amine-containing drugs: analysis and therapeutic implications.
Kaufmann AM; Krise JP
J Pharm Sci; 2007 Apr; 96(4):729-46. PubMed ID: 17117426
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of Lysosomal Trapping of Basic Lipophilic Compounds Using In Vitro Assays and In Silico Predictions Based on the Determination of the Full pH Profile of the Endo-/Lysosomal System in Rat Hepatocytes.
Schmitt MV; Lienau P; Fricker G; Reichel A
Drug Metab Dispos; 2019 Jan; 47(1):49-57. PubMed ID: 30409837
[TBL] [Abstract][Full Text] [Related]
14. Lysosomal localization and mechanism of uptake of Nile blue photosensitizers in tumor cells.
Lin CW; Shulok JR; Kirley SD; Cincotta L; Foley JW
Cancer Res; 1991 May; 51(10):2710-9. PubMed ID: 2021950
[TBL] [Abstract][Full Text] [Related]
15. Lysosomal sequestration (trapping) of lipophilic amine (cationic amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells).
Kazmi F; Hensley T; Pope C; Funk RS; Loewen GJ; Buckley DB; Parkinson A
Drug Metab Dispos; 2013 Apr; 41(4):897-905. PubMed ID: 23378628
[TBL] [Abstract][Full Text] [Related]
16. Lysosomotropic Drugs: Pharmacological Tools to Study Lysosomal Function.
Pisonero-Vaquero S; Medina DL
Curr Drug Metab; 2017; 18(12):1147-1158. PubMed ID: 28952432
[TBL] [Abstract][Full Text] [Related]
17. Lysosomotropic agents: impact on lysosomal membrane permeabilization and cell death.
Villamil Giraldo AM; Appelqvist H; Ederth T; Öllinger K
Biochem Soc Trans; 2014 Oct; 42(5):1460-4. PubMed ID: 25233432
[TBL] [Abstract][Full Text] [Related]
18. Growth inhibition of 3T3 fibroblasts by lysosomotropic amines: correlation with effects on intravesicular pH but not vacuolation.
Cain CC; Murphy RF
J Cell Physiol; 1986 Oct; 129(1):65-70. PubMed ID: 3760033
[TBL] [Abstract][Full Text] [Related]
19. Interactions between promazine and antidepressants at the level of cellular distribution.
Daniel WA; Wójcikowski J
Pharmacol Toxicol; 1997 Dec; 81(6):259-64. PubMed ID: 9444666
[TBL] [Abstract][Full Text] [Related]
20. Effect of lysosomotropic molecules on cellular homeostasis.
Kuzu OF; Toprak M; Noory MA; Robertson GP
Pharmacol Res; 2017 Mar; 117():177-184. PubMed ID: 28025106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
